Consolidated Statements of Changes in Mezzanine Equity and Stockholders’ Equity - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021			106,308,767
Beginning balance at Dec. 31, 2021	$ 309,852		$ 106	$ 682,084	$ (372,164)	$ (174)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock as dividend on convertible preferred stock (in shares)			61,280
Issuance of common stock pursuant to employee stock purchase program (in shares)			661,054
Issuance of common stock pursuant to employee stock purchase program	4,630		$ 1	4,629
Stock issued during period, value, stock options exercised (in shares)			645,120
Issuance of common stock pursuant to exercise of stock options	4,628			4,628
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			1,056,468
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 1	(1)
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			316,750
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(3,743)			(3,743)
Stock-based compensation	35,654			35,654
Other comprehensive loss	(816)					(816)
Net loss	(168,952)				(168,952)
Ending balance (in shares) at Jun. 30, 2022			108,415,939
Ending balance at Jun. 30, 2022	181,253		$ 108	723,251	(541,116)	(990)
Beginning balance (in shares) at Dec. 31, 2021		40,000
Beginning balance at Dec. 31, 2021		$ 39,868
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net		$ 23
Ending balance (in shares) at Jun. 30, 2022		40,000
Ending balance at Jun. 30, 2022		$ 39,891
Beginning balance (in shares) at Mar. 31, 2022			107,025,691
Beginning balance at Mar. 31, 2022	235,623		$ 107	699,225	(462,970)	(739)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock as dividend on convertible preferred stock (in shares)			30,640
Issuance of common stock pursuant to employee stock purchase program (in shares)			661,054
Issuance of common stock pursuant to employee stock purchase program	4,630		$ 1	4,629
Stock issued during period, value, stock options exercised (in shares)			436,621
Issuance of common stock pursuant to exercise of stock options	2,813			2,813
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			372,111
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			110,178
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(1,148)			(1,148)
Stock-based compensation	17,732			17,732
Other comprehensive loss	(251)					(251)
Net loss	(78,146)				(78,146)
Ending balance (in shares) at Jun. 30, 2022			108,415,939
Ending balance at Jun. 30, 2022	181,253		$ 108	723,251	(541,116)	(990)
Beginning balance (in shares) at Mar. 31, 2022		40,000
Beginning balance at Mar. 31, 2022		$ 39,879
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net	$ 0	$ 12
Ending balance (in shares) at Jun. 30, 2022		40,000
Ending balance at Jun. 30, 2022		$ 39,891
Beginning balance (in shares) at Dec. 31, 2022	109,696,178		109,696,178
Beginning balance at Dec. 31, 2022	$ 63,953		$ 110	757,951	(693,307)	(801)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock as dividend on convertible preferred stock (in shares)	30,640		61,280
Issuance of common stock pursuant to employee stock purchase program (in shares)			1,150,703
Issuance of common stock pursuant to employee stock purchase program	$ 4,215		$ 1	4,214
Stock issued during period, value, stock options exercised (in shares)	563,164		563,164
Issuance of common stock pursuant to exercise of stock options	$ 1,450		$ 0	1,450
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			3,568,639
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 4	(4)
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			1,105,291
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(11,096)		$ 1	(11,095)
Stock-based compensation	38,786			38,786
Other comprehensive loss	349					349
Net loss	$ (88,156)				(88,156)
Ending balance (in shares) at Jun. 30, 2023	113,934,673		113,934,673
Ending balance at Jun. 30, 2023	$ 9,501		$ 114	791,302	(781,463)	(452)
Beginning balance (in shares) at Dec. 31, 2022	40,000	40,000
Beginning balance at Dec. 31, 2022	$ 39,914	$ 39,914
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net		$ 22
Ending balance (in shares) at Jun. 30, 2023	40,000	40,000
Ending balance at Jun. 30, 2023	$ 39,936	$ 39,936
Beginning balance (in shares) at Mar. 31, 2023			110,526,884
Beginning balance at Mar. 31, 2023	20,664		$ 110	775,094	(754,105)	(435)
Increase (Decrease) in Stockholders' Equity
Issuance of common stock as dividend on convertible preferred stock (in shares)			30,640
Issuance of common stock pursuant to employee stock purchase program (in shares)			1,150,703
Issuance of common stock pursuant to employee stock purchase program	4,215		$ 1	4,214
Stock issued during period, value, stock options exercised (in shares)			545,127
Issuance of common stock pursuant to exercise of stock options	1,312		$ 2	1,310
Issuance of common stock pursuant to settlement of restricted stock units (in shares)			2,412,813
Issuance of common stock pursuant to settlement of restricted stock units	0		$ 2	(2)
Common stock surrendered for employees' tax liability upon settlement or restricted stock units (in shares)			731,494
Common stock surrendered for employees' tax liability upon settlement of restricted stock units	(7,937)		$ 1	(7,936)
Stock-based compensation	18,622			18,622
Other comprehensive loss	(17)					(17)
Net loss	$ (27,358)				(27,358)
Ending balance (in shares) at Jun. 30, 2023	113,934,673		113,934,673
Ending balance at Jun. 30, 2023	$ 9,501		$ 114	$ 791,302	$ (781,463)	$ (452)
Beginning balance (in shares) at Mar. 31, 2023		40,000
Beginning balance at Mar. 31, 2023		$ 39,925
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net		$ 11
Ending balance (in shares) at Jun. 30, 2023	40,000	40,000
Ending balance at Jun. 30, 2023	$ 39,936	$ 39,936